Embecta Completes £150m Acquisition of Owen Mumford to Expand Chronic Care and Drug Delivery Portfolio

Embecta has formally completed its acquisition of UK-based medical device manufacturer Owen Mumford Holdings in a transaction valued at up to £150 million (approximately $172.6 million). The Embecta Owen Mumford acquisition, first announced in March 2026, positions the combined entity to deliver a broader suite of drug delivery and chronic care solutions to pharmaceutical partners […]

The post Embecta Completes £150m Acquisition of Owen Mumford to Expand Chronic Care and Drug Delivery Portfolio first appeared on HHM Global | B2B Online Platform & Magazine.